Mimedx (MDXG) Enterprise Value (2010 - 2026)

Mimedx has disclosed Enterprise Value across 17 years of filings, most recently posting $425.2 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 45.83% year-over-year to $425.2 million; the TTM figure through Jun 2026 stood at $425.2 million (down 45.83% YoY), while the FY2025 annual figure was $836.5 million, down 36.1% from the prior year.
• Enterprise Value came in at $425.2 million for Q2 2026 at Mimedx, down from $428.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $1.3 billion in Q4 2024 to a low of $250.2 million in Q4 2022.
• Average Enterprise Value over 5 years is $700.5 million, with a median of $782.4 million recorded in 2024.
• Year-over-year, Enterprise Value tumbled 75.53% in 2022 and soared 275.64% in 2023.
• Over 5 years, Enterprise Value stood at $250.2 million in 2022, then soared by 275.64% to $939.7 million in 2023, then soared by 39.31% to $1.3 billion in 2024, then plunged by 36.1% to $836.5 million in 2025, then slumped by 49.17% to $425.2 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $425.2 million in Q2 2026, $428.5 million in Q1 2026, and $836.5 million in Q4 2025.